“Adjuvant Formulation for use in Vaccines to Elicit Both Cell-Mediated and Humoral Immunity” Vaccine 1987, 5:223-228. Martinon et al. “Efficacy of a ‘One Shot’ Schedule of a Mycoplasma Hyopneumoniae Bacteria (Hyoresp)” Proceedings of the 15th IPVS Congress, Birmingham, England, Jul. ...
This is the first vaccine administered intradermally using a needle-free device that protects from both agents simul- taneously. In previous studies, MHYOSPHERE® PCV ID has been proven to induce onset of immunity for Mhyo and PCV2 as early as 3 and 2 weeks post-vaccination, respec- ...
During May 1,2010-April 30,2011,63 vaccine-eligible children with IPD caused by a serotype that would have been prevented by PCV13 were identified within 12 study regions. Most of those children were aged 24 through 59 months and were vaccinated completely with PCV7 but had not received the...
Cont. Name Affiliation Brita A. Winje Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway Khalid Zerouali Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 20000, Morocco; Bacteriology-Virology ...
In 2014, to help strengthen the refrigerated vaccine supply chain-the "cold chain"-in underserved regions, AUCMA and Global Good have partnered to provide Arktek. Both parties share the same value that saves the children by vaccination...